Form 4 for ISRG Intuitive Surgical
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-11 · accession 0001035267-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-12 | 2025-03-11+ | ISRG | Miller Brian Edward | EVP, Chief Digital Off | S - Sale+OE | $493.44 | -12.9K | 5,758 | -69% | -$6.37M |
| DM | 2025-03-12 | 2025-03-11+ | ISRG | Miller Brian Edward | EVP, Chief Digital Off | M - OptEx | $190.97 | +5,834 | 8,208 | +246% | +$1.11M |
| DM | 2025-03-12 | 2025-03-11+ | ISRG | Miller Brian Edward | EVP, Chief Digital Off | M - OptEx | $0.00 | -5,834 | 4,317 | -57% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-12 | S | D | 2,450 | $512.06 | 5,758 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-11 | M | A | 1,834 | $177.99 | 14,658 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-11 | S | D | 1,834 | $485.96 | 12,824 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $479.78 to $489.50 as follows: 243 shares sold at $479.78 to $480.75; 200 shares sold at $480.99to $481.50; 100 shares sold at $483.59; 100 shares sold at $485.39; 791 shares sold at $487.20 to $488.09; and 400 shares sold at $488.52 to $489.50. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-03-11 | S | D | 442 | $482.82 | 12,382 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $480.67 to $489.28 as follows: 270 shares sold at $480.67 to $480.99; 100 shares sold at $483.59; and 72 shares sold at $489.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-03-11 | S | D | 6,624 | $484.97 | 5,758 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $478.45 to $490.19 as follows: 702 shares sold at $478.45 to $479.29; 1,330 shares sold at $480.41 to $481.13; 200 shares sold at $481.50 to $482.50; 500 shares sold at $482.76 to $483.03; 358 shares sold at $485.39 to $486.00; 2,377 shares sold at $487.20 to $488.09; 975 shares sold at $488.52 to $489.50; and 182 shares sold at $489.69 to $490.19. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-03-12 | M | A | 1,550 | $177.99 | 7,308 | D | — | — | |
| 7 | Common | Common Stock | 2025-03-12 | S | D | 1,550 | $512.06 | 5,758 | D | — | — | |
| 8 | Common | Common Stock | 2025-03-12 | M | A | 2,450 | $208.90 | 8,208 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-12 | M | D | 1,550 | $0.00 | 0 | D | $177.99 · — to 2030-02-28 | 1,550 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-11 | M | D | 1,834 | $0.00 | 1,550 | D | $177.99 · — to 2030-02-28 | 1,834 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-12 | M | D | 2,450 | $0.00 | 4,317 | D | $208.90 · — to 2029-08-28 | 2,450 Common Stock | (F6) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |